Lancet Study Outlines First Risk Calculator for Pediatric Hypertrophic Cardiomyopathy | Miller School of Medicine | University of Miami

Lancet Study Outlines First Risk Calculator for Pediatric Hypertrophic Cardiomyopathy | Miller School of Medicine | University of Miami

NHLBI in the News University of Miami Miller School of Medicine Lancet study outlines first risk calculator for pediatric hypertrophic cardiomyopathy NHLBI-supported researchers at the University of Miami found that risk factors identified at diagnosis help predict outcomes for children with a complex heart condition called hypertrophic cardiomyopathy (HCM). “Based on our experience with adults, we do not think of hypertrophic cardiomyopathy as a cause for heart transplant. Yet for a select group of high-risk children with HCM, a heart transplant is key for survival,” said principal investigator Steven E. Lipshultz, M.D.